Compare Oklo Inc (OKLO) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs Health Care Select Sector SPDR Fund — how do they compare? Oklo Inc trades at $42.64 (market cap $7.92B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| OKLO | XLV | |
|---|---|---|
Market Cap | $7.92B | — |
Sector | Technology | — |
52-Week High | $174.14 | $175.68 |
52-Week Low | $36.84 | $134.13 |
Enterprise Value | $5.46B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $43.31, up 4.94% in the last 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The stock shows significant losses with a net income margin of -12,625.54% and negative cash flow from operations, but strong financing inflows support growth investments. Recent news highlights progress in small modular reactor projects amid sector volatility, with a 52-week low of $36.61 indicating potential support levels.
Outlook: Wall Street consensus is bullish with a $71.58 price target, driven by AI power demand and nuclear energy tailwinds. Risks include project delays, high cash burn, and lack of profitability. The stock offers high growth potential but requires tolerance for execution risk and extended timelines to commercialization.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
